Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lippo Group is a prominent Indonesian conglomerate with a significant footprint in the healthcare industry through its subsidiary, Siloam Hospitals. As the largest private healthcare provider in Indonesia, the group operates an extensive network of hospitals and clinics, offering a wide range of tertiary care services including oncology, cardiology, and emergency medicine. The company's healthcare strategy is further supported by the Mochtar Riady Institute for Nanotechnology (MRIN), a private research institution focused on cancer genomics and molecular biology. Lippo Group integrates its medical services with its broader real estate and digital ecosystems to enhance regional medical infrastructure and patient access. Their clinical focus areas include specialized centers for neuroscience and orthopedics, often utilizing advanced diagnostic and therapeutic technologies. Through international partnerships and a commitment to medical education, the group aims to elevate the standard of healthcare across Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lippo Group.